Hercules Capital에 대한 매도 수량은 투자자에게 Hercules Capital의 주식 하락에 베팅하는 정도를 알려줍니다. 매도 수량 데이터는 2주마다 업데이트됩니다.

Hercules Capital (NYSE:HTGC) 주식, 공매도 수량 보고

Hercules Capital

Hercules Capital Inc is a specialty finance company engaged in providing senior secured loans to high-growth, venture capital-backed companies in a variety of technology, life sciences, and sustainable and renewable technology industries. It invests majorly in structured debt with warrants and, to a lesser extent, in senior debt and equity investments. The company lends to and invests in portfolio companies in various technology-related industries including technology, drug discovery and development, biotechnology, life sciences, healthcare, and sustainable and renewable technology.

Hercules Capital Inc

Hercules Capital's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HTGC#NYSE">HTGC</a>) short percent of float has fallen 3.83% since its last report. The company recently reported that it has 6.00 million shares sold short, which is 3.77% of all regular shares that are available for trading. Based on its trading volume, it would take traders 7.36 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Hercules Capital Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1723746617_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Hercules Capital has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Hercules Capital's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Hercules Capital's peer group average for short interest as a percentage of float is 3.81%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

Trading Ideas

HTGC

(HTGC) - Analyzing Hercules Capital's Short Interest

WIIM

ACRE

ALLY

ARES

ATCH

COHN

CRBG

FUTU

HIPO

HOOD

HSBC

IBKR

JFIN

Janus Henderson Group plc Ordinary Shares

KSPI

LPLA

MOGO

MORN

NCPL

NDAQ

NRDS

NTRS

PRAA

RILY

SHF Holdings, Inc. - Class A Common Stock

SHFS

SNEX

SPGI

STEP

TBBK

TROW

VCTR

VOYA

Shares of companies within the broader financial sector are trading lower amid overall weakness following concerns about recently issued US economic data.

Hercules Capital shares are trading lower after the company reported worse-than-expected Q2 revenue results.

Piper Sandler analyst Crispin Love maintains Hercules Capital (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HTGC#NYSE">HTGC</a>) with a Overweight and raises the price target from $22 to $22.5.

News

Price Target

Analyst Ratings

Piper Sandler Maintains Overweight on Hercules Capital, Raises Price Target to $22.5

Hercules Capital (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HTGC#NYSE">HTGC</a>) reported quarterly earnings of $0.51 per share which met the analyst consensus estimate. This is a 3.77 percent decrease over earnings of $0.53 per share from the same period last year. The company reported quarterly sales of $125.006 million which missed the analyst consensus estimate of $127.526 million by 1.98 percent. This is a 7.55 percent increase over sales of $116.231 million the same period last year.

Earnings

Earnings Misses

Hercules Capital Q2 2024 GAAP EPS $0.51, Inline, Sales $125.006M Miss $127.526M Estimate

JMP Securities analyst Devin Ryan maintains Hercules Capital (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HTGC#NYSE">HTGC</a>) with a Market Outperform and raises the price target from $20 to $22.

JMP Securities Maintains Market Outperform on Hercules Capital, Raises Price Target to $22

Analysts' ratings for Hercules Capital (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HTGC#NYSE">HTGC</a>) over the last quarter vary from bullish to bearish, as provided by 6 analysts.
The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">5</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
Analysts have set 12-month price targets for Hercules Capital, revealing an average target of $20.75, a high estimate of $22.00, and a low estimate of $19.00. Witnessing a positive shift, the current average has risen by 4.64% from the previous average price target of $19.83.
<img src="https://www.benzinga.com/files/images/story/2024/1722009619_0.png" alt="price target chart" />
<h2>Deciphering Analyst Ratings: An In-Depth Analysis</h2>
The perception of Hercules Capital by financial experts is analyzed through recent analyst actions. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Finian O'Shea</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Overweight</td>
<td>$22.00</td>
<td>$20.00</td>
</tr>
<tr>
<td>Crispin Love</td>
<td>Piper Sandler</td>
<td>Raises</td>
<td>Overweight</td>
<td>$22.00</td>
<td>$21.50</td>
</tr>
<tr>
<td>Devin Ryan</td>
<td>JMP Securities</td>
<td>Raises</td>
<td>Market Outperform</td>
<td>$20.00</td>
<td>$19.00</td>
</tr>
<tr>
<td>Finian O'Shea</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Overweight</td>
<td>$20.00</td>
<td>$19.50</td>
</tr>
<tr>
<td>Crispin Love</td>
<td>Piper Sandler</td>
<td>Raises</td>
<td>Overweight</td>
<td>$21.50</td>
<td>$21.00</td>
</tr>
<tr>
<td>Paul Johnson</td>
<td>Keefe, Bruyette &amp; Woods</td>
<td>Raises</td>
<td>Market Perform</td>
<td>$19.00</td>
<td>$18.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Hercules Capital. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Delving into assessments, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings communicate expectations for the relative performance of Hercules Capital compared to the broader market.</li>
<li>Price Targets: Analysts predict movements in price targets, offering estimates for Hercules Capital's future value. Examining the current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
Understanding these analyst evaluations alongside key financial indicators can offer valuable insights into Hercules Capital's market standing. Stay informed and make well-considered decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/HTGC/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Hercules Capital analyst ratings.</a>
<h2>All You Need to Know About Hercules Capital</h2>
Hercules Capital Inc is a specialty finance company engaged in providing senior secured loans to high-growth, venture capital-backed companies in a variety of technology, life sciences, and sustainable and renewable technology industries. It invests majorly in structured debt with warrants and, to a lesser extent, in senior debt and equity investments. The company lends to and invests in portfolio companies in various technology-related industries including technology, drug discovery and development, biotechnology, life sciences, healthcare, and sustainable and renewable technology.
<h3>Financial Milestones: Hercules Capital's Journey</h3>
Market Capitalization Analysis: The company's market capitalization is below the industry average, suggesting that it is relatively smaller compared to peers. This could be due to various factors, including perceived growth potential or operational scale.
Revenue Challenges: Hercules Capital's revenue growth over 3 months faced difficulties. As of 31 March, 2024, the company experienced a decline of approximately -1.53%. This indicates a decrease in top-line earnings. When compared to others in the Financials sector, the company faces challenges, achieving a growth rate lower than the average among peers.
Net Margin: The company's net margin is a standout performer, exceeding industry averages. With an impressive net margin of 78.6%, the company showcases strong profitability and effective cost control.
Return on Equity (ROE): Hercules Capital's ROE stands out, surpassing industry averages. With an impressive ROE of 4.93%, the company demonstrates effective use of equity capital and strong financial performance.
Return on Assets (ROA): The company's ROA is a standout performer, exceeding industry averages. With an impressive ROA of 2.56%, the company showcases effective utilization of assets.
Debt Management: Hercules Capital's debt-to-equity ratio surpasses industry norms, standing at 0.94. This suggests the company carries a substantial amount of debt, posing potential financial challenges.
<h2>The Core of Analyst Ratings: What Every Investor Should Know</h2>
Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.
Analysts may enhance their evaluations by incorporating forecasts for metrics like growth estimates, earnings, and revenue, delivering additional guidance to investors. It is vital to acknowledge that, although experts in stocks and sectors, analysts are human and express their opinions when providing insights.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Key Takeaways From Hercules Capital Analyst Ratings

Wells Fargo analyst Finian O'Shea maintains Hercules Capital (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HTGC#NYSE">HTGC</a>) with a Overweight and raises the price target from $20 to $22.

Wells Fargo Maintains Overweight on Hercules Capital, Raises Price Target to $22

Hercules Capital Announced That The U.S. Small Business Administration Has Approved Its Fourth Small Business Investment Company Subsidiary, Following The Company's Prior Receipt Of Its "Green Light" Letter To Submit An Application

5 analysts have expressed a variety of opinions on Hercules Capital (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HTGC#NYSE">HTGC</a>) over the past quarter, offering a diverse set of opinions from bullish to bearish.
Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">4</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
Insights from analysts' 12-month price targets are revealed, presenting an average target of $20.5, a high estimate of $22.00, and a low estimate of $19.00. Observing a 3.54% increase, the current average has risen from the previous average price target of $19.80. 
<img src="https://www.benzinga.com/files/images/story/2024/1720627247_0.png" alt="price target chart" />
<h2>Decoding Analyst Ratings: A Detailed Look</h2>
A clear picture of Hercules Capital's perception among financial experts is painted with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Crispin Love</td>
<td>Piper Sandler</td>
<td>Raises</td>
<td>Overweight</td>
<td>$22.00</td>
<td>$21.50</td>
</tr>
<tr>
<td>Devin Ryan</td>
<td>JMP Securities</td>
<td>Raises</td>
<td>Market Outperform</td>
<td>$20.00</td>
<td>$19.00</td>
</tr>
<tr>
<td>Finian O'Shea</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Overweight</td>
<td>$20.00</td>
<td>$19.50</td>
</tr>
<tr>
<td>Crispin Love</td>
<td>Piper Sandler</td>
<td>Raises</td>
<td>Overweight</td>
<td>$21.50</td>
<td>$21.00</td>
</tr>
<tr>
<td>Paul Johnson</td>
<td>Keefe, Bruyette &amp; Woods</td>
<td>Raises</td>
<td>Market Perform</td>
<td>$19.00</td>
<td>$18.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Hercules Capital. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li>Rating: Gaining insights, analysts provide qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Hercules Capital compared to the broader market.</li>
<li>Price Targets: Analysts navigate through adjustments in price targets, providing estimates for Hercules Capital's future value. Comparing current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
For valuable insights into Hercules Capital's market performance, consider these analyst evaluations alongside crucial financial indicators. Stay well-informed and make prudent decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/HTGC/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Hercules Capital analyst ratings.</a>
<h2>Unveiling the Story Behind Hercules Capital</h2>
Hercules Capital Inc is a specialty finance company engaged in providing senior secured loans to high-growth, venture capital-backed companies in a variety of technology, life sciences, and sustainable and renewable technology industries. It invests majorly in structured debt with warrants and, to a lesser extent, in senior debt and equity investments. The company lends to and invests in portfolio companies in various technology-related industries including technology, drug discovery and development, biotechnology, life sciences, healthcare, and sustainable and renewable technology.
<h3>Financial Insights: Hercules Capital</h3>
Market Capitalization: With restricted market capitalization, the company is positioned below industry averages. This reflects a smaller scale relative to peers.
Revenue Challenges: Hercules Capital's revenue growth over 3 months faced difficulties. As of 31 March, 2024, the company experienced a decline of approximately -1.53%. This indicates a decrease in top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Financials sector.
Net Margin: The company's net margin is a standout performer, exceeding industry averages. With an impressive net margin of 78.6%, the company showcases strong profitability and effective cost control.
Return on Equity (ROE): Hercules Capital's ROE surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 4.93% ROE, the company effectively utilizes shareholder equity capital.
Return on Assets (ROA): Hercules Capital's ROA stands out, surpassing industry averages. With an impressive ROA of 2.56%, the company demonstrates effective utilization of assets and strong financial performance.
Debt Management: Hercules Capital's debt-to-equity ratio is notably higher than the industry average. With a ratio of 0.94, the company relies more heavily on borrowed funds, indicating a higher level of financial risk.
<h2>Understanding the Relevance of Analyst Ratings</h2>
Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

In-Depth Examination Of 5 Analyst Recommendations For Hercules Capital

Piper Sandler analyst Crispin Love maintains Hercules Capital (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HTGC#NYSE">HTGC</a>) with a Overweight and raises the price target from $21.5 to $22.

Piper Sandler Maintains Overweight on Hercules Capital, Raises Price Target to $22

Health Care

Financing

General

NEUE

Neuehealth Entered Into A Secured Loan Facility For Up To $150M With Hercules Capital

On CNBC's &#8220;<a href="https://www.cnbc.com/video/2024/05/17/final-trades-alphabet-honeywell-prudential-and-hercules-capital.html&quot;">Halftime Report Final Trades</a>,&#8221; Stephen Weiss of Short Hills Capital Partners said Alphabet Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOG#NASDAQ">GOOG</a>) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>) has been on a roll and will continue to be. The company had a great developers conference and <a href="https://www.benzinga.com/news/24/05/38864502/google-comes-up-with-ai-powered-theft-prevention-lock-to-secure-android-devices-against-snatching">made great announcements</a>, he said. 
Google last week announced a new feature that will use artificial intelligence to detect theft and lock the screen of Android smartphones.
Kevin Simpson of Capital Wealth Planning said Honeywell International Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HON#NASDAQ">HON</a>) has increasing cash flow and margins. He expects analysts to increase estimates and price targets for the stock.
On April 25, Honeywell International reported first-quarter fiscal 2024 sales of $9.105 billion. That's up 3% year-over-year on a reported basis and and increase of 3% on an organic basis, beating the consensus of $9.03 billion.
Don't forget to check out our <a href="https://www.benzinga.com/premarket/">premarket coverage here</a>.
Jason Snipe of Odyssey Capital Advisors said Prudential Financial, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PRU#NYSE">PRU</a>) has a 4.4% dividend yield.
On May 13, Prudential Financial named Andrew Yorks as head of Global Investment Strategy, effective July 15.
Jenny Van Leeuwen Harrington of Gilman Hill Asset Management, LLC said Hercules Capital, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HTGC#NYSE">HTGC</a>) has a 8.3% dividend yield.
On May 2, Hercules Capital posted better-than-expected quarterly sales results.
Price Action:
<ul>
<li>Alphabet shares rose 1.1% to close at $177.29 on Friday.</li>
<li>Honeywell fell 0.3% to settle at $205.97 during Friday's session.</li>
<li>Prudential Financial shares gained 1.2% to settle at $121.31 on Friday.</li>
<li>Hercules Capital shares rose 1.5% to close at $19.36 on Friday.</li>
</ul>
Check This Out: <a href="https://www.benzinga.com/trading-ideas/long-ideas/24/05/38893373/insiders-buying-turtle-beach-and-3-other-stocks">Insiders Buying Turtle Beach And 3 Other Stocks</a>
Photo via Shutterstock.

Long Ideas

Markets

Media

GOOG

GOOGL

Honeywell, Prudential Financial, Hercules Capital And A Major Tech Stock On CNBC's 'Final Trades'

CNBC Halftime Report Final Trades: Hercules Capital, Prudential Financial, Honeywell International, Alphabet Inc. - Class C

JMP Securities analyst Devin Ryan maintains Hercules Capital (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HTGC#NYSE">HTGC</a>) with a Market Outperform and raises the price target from $19 to $20.

JMP Securities Maintains Market Outperform on Hercules Capital, Raises Price Target to $20

Wells Fargo analyst Finian O'Shea maintains Hercules Capital (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HTGC#NYSE">HTGC</a>) with a Overweight and raises the price target from $19.5 to $20.

Wells Fargo Maintains Overweight on Hercules Capital, Raises Price Target to $20

Piper Sandler analyst Crispin Love maintains Hercules Capital (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HTGC#NYSE">HTGC</a>) with a Overweight and raises the price target from $21 to $21.5.

Piper Sandler Maintains Overweight on Hercules Capital, Raises Price Target to $21.5

Keefe, Bruyette &amp; Woods analyst Paul Johnson maintains Hercules Capital (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HTGC#NYSE">HTGC</a>) with a Market Perform and raises the price target from $18 to $19.

Keefe, Bruyette & Woods Maintains Market Perform on Hercules Capital, Raises Price Target to $19

Hercules Capital (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HTGC#NYSE">HTGC</a>) reported quarterly earnings of $0.50 per share which missed the analyst consensus estimate of $0.51 by 1.96 percent. This is a 4.17 percent increase over earnings of $0.48 per share from the same period last year. The company reported quarterly sales of $121.553 million which beat the analyst consensus estimate of $119.016 million by 2.13 percent. This is a 15.67 percent increase over sales of $105.090 million the same period last year.

Earnings Beats

Hercules Capital Q1 2024 GAAP EPS $0.50 Misses $0.51 Estimate, Sales $121.553M Beat $119.016M Estimate

Hercules Capital (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HTGC#NYSE">HTGC</a>) reported quarterly earnings of $0.50 per share which met the analyst consensus estimate. This is a 4.17 percent increase over earnings of $0.48 per share from the same period last year. The company reported quarterly sales of $121.60 million which beat the analyst consensus estimate of $119.02 million by 2.17 percent. This is a 15.71 percent increase over sales of $105.09 million the same period last year.

Hercules Capital Q1 EPS $0.50, Inline, Sales $121.60M Beat $119.02M Estimate

Are Rate Cuts Bad News For BIZD ETF?

Hercules Capital: The Yield And Underlying Value Remain Attractive

Is Hercules Capital Worthy Of Its Name? Volatility Is Coming

5 Dividend Stocks And 1 ETF I'm Buying As The Energy Sector Slumps

Capital Southwest: 10% Quality Yield Has Its Price

Trinity Capital: Positioned Well For A Post-High Interest Rate Environment

Blue Owl Capital Inc. leads $3.2B private debt financing for Smartsheet - report

My Dividend Stock Portfolio: New August Dividend Record - 101 Holdings With 17 Buys

The Best BDC To Buy For Fed Rate Cuts

Trinity Capital: 15% Yield With Room For Improvement

AAPL

ABBV

AGNC

ALIZF

APLE

ARCC

AVGO

BABA

BASFY

BIZD

BMWYY

BXSL

CBAUF

CMCSA

CSCO

CSWC

GAIN

GBDC

GILD

GLAD

GOOD

GSBD

HCXY

HRZN

INTC

MAIN

MCQEF

MFIC

MLPA

MLPX

MQBKY

MRCC

MSDL

MSFT

NVDA

OBDC

OCSL

PSEC

RITM

SEMHF

SGOV

SHEL

SMAR

STAG

STWD

TPVG

TRIN

TSLX

UNIT

VONOY

Press Releases

NeueHealth Secures up to $150 Million in New Term Loan Facility with Hercules Capital

Hercules Capital Receives SBA Approval for Its Fourth SBIC License

Pindrop Secures $100 Million Financing To Accelerate Fraud And Deepfake Detection Technologies

Hercules Capital Announces Date for Release of Second Quarter 2024 Financial Results and Conference Call

Hercules Capital Declares a Total Cash Distribution of $0.48 Per Share for the Second Quarter 2024

Thumbtack Announces $75 Million in Financing from Silicon Valley Bank and Hercules Capital

Hercules Capital Reports Second Quarter 2024 Financial Results

Hercules Capital Receives a BBB+ Reaffirmed Investment Grade Corporate Rating from Kroll Bond Rating Agency, Inc.

Arcus Biosciences Secures Up to $250 Million Term Loan Facility from Hercules Capital

Comments

Hercules Capital

매도 수량

Hercules Capital (NYSE:HTGC) 주식, 공매도 수량 보고

사람들이 또한 지켜본다

뉴스

파트너 / 기고자

벤징가 글로벌